Cargando…
Flexible, rule-based dose escalation: The cohort-sequence design
Phase I oncology trials seek to acquire preliminary information on the safety of novel treatments. In current practice, most such trials employ rule-based designs that determine whether to escalate the dose using data from the current dose only. The most popular of these, the 3 + 3, is simple and fa...
Autores principales: | Li, Shuang, Xie, Xian-Jin, Heitjan, Daniel F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029255/ https://www.ncbi.nlm.nih.gov/pubmed/32099932 http://dx.doi.org/10.1016/j.conctc.2020.100541 |
Ejemplares similares
-
Addressing the barriers to implementing model based designs in dose escalation studies
por: Cornelius, Victoria, et al.
Publicado: (2015) -
Evolving rule-based models: a tool for design of flexible adaptive systems
por: Kacprzyk, Janusz, et al.
Publicado: (1999) -
Some small sample properties of the EWOC design in dose escalation trials
por: Kinnersley, Nelson
Publicado: (2015) -
Dose escalation of a curcuminoid formulation
por: Lao, Christopher D, et al.
Publicado: (2006) -
Efficiency of New Dose Escalation Designs in Dose-Finding Phase I Trials of Molecularly Targeted Agents
por: Le Tourneau, Christophe, et al.
Publicado: (2012)